Alkermes Plc (ALKS)
29.36
-0.30
(-1.01%)
USD |
NASDAQ |
Jan 12, 09:30
Alkermes Research and Development Expense (Quarterly): 80.34M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 27.01M |
| CorMedix, Inc. | 5.098M |
| Jazz Pharmaceuticals Plc | 198.20M |
| Amarin Corp. Plc | 3.321M |
| Amicus Therapeutics, Inc. | 23.42M |